tradingkey.logo

Fortrea Holdings Inc

FTRE
10.120USD
-0.340-3.25%
Fechamento 11/03, 16:00ETCotações atrasadas em 15 min
918.90MValor de mercado
PerdaP/L TTM

Fortrea Holdings Inc

10.120
-0.340-3.25%

Mais detalhes de Fortrea Holdings Inc Empresa

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Informações de Fortrea Holdings Inc

Código da empresaFTRE
Nome da EmpresaFortrea Holdings Inc
Data de listagemJun 16, 2023
CEOMr. Anshul Thakrala
Número de funcionários15500
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 16
Endereço8 Moore Drive
CidadeDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27709
Telefone18774950816
Sitehttps://www.fortrea.com/
Código da empresaFTRE
Data de listagemJun 16, 2023
CEOMr. Anshul Thakrala

Executivos da empresa Fortrea Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Outro
55.93%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Outro
55.93%
Tipos de investidores
Investidores
Proporção
Investment Advisor
45.71%
Hedge Fund
24.43%
Investment Advisor/Hedge Fund
22.87%
Research Firm
13.87%
Bank and Trust
2.55%
Pension Fund
2.34%
Individual Investor
0.52%
Family Office
0.39%
Sovereign Wealth Fund
0.05%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
948
101.58M
111.87%
-11.06M
2025Q2
941
91.16M
100.39%
-22.39M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Starboard Value LP
2.50M
2.75%
-220.86K
-8.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.17M
2.39%
+589.14K
+37.23%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
Brandes US Small-Mid Cap Value ETF
1.13%
Invesco S&P Spin-Off ETF
0.83%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco S&P SmallCap 600 Pure Value ETF
0.19%
Invesco S&P SmallCap 600 Revenue ETF
0.17%
Schwab Fundamental U.S. Small Company ETF
0.14%
Humankind US Stock ETF
0.12%
SPDR S&P 600 Small Cap Value ETF
0.11%
iShares S&P Small-Cap 600 Value ETF
0.11%
ProShares Ultra Nasdaq Biotechnology
0.08%
Ver Mais
Brandes US Small-Mid Cap Value ETF
Proporção1.13%
Invesco S&P Spin-Off ETF
Proporção0.83%
Invesco S&P SmallCap Health Care ETF
Proporção0.49%
Invesco S&P SmallCap 600 Pure Value ETF
Proporção0.19%
Invesco S&P SmallCap 600 Revenue ETF
Proporção0.17%
Schwab Fundamental U.S. Small Company ETF
Proporção0.14%
Humankind US Stock ETF
Proporção0.12%
SPDR S&P 600 Small Cap Value ETF
Proporção0.11%
iShares S&P Small-Cap 600 Value ETF
Proporção0.11%
ProShares Ultra Nasdaq Biotechnology
Proporção0.08%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI